BioCardia®, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces it has completed a third preliminary ...

Mayo Clinic researchers have uncovered how aging "zombie cells" trigger harmful inflammation that accelerates a severe and ...

A PLEASANTVILLE man on remand for the murder of a police officer in 2013 was found dead in a cell at the Port of Spain Prison ...

In this installment of The OncoloGIST, Hans Lee, MD, director of Myeloma Research at Sarah Cannon Research Institute, ...

Two recent studies show the novel therapy works in people with multiple myeloma, but researchers are trying to minimize side ...

Immutep (IMMP) reports strong operational progress in the TACTI-004 Phase III trial evaluating eftilagimod alfa in combination with MSD’s (MRK) ...

Closes $60 Million Series A Financing Round Backed by New and Existing Investors$92 Million Raised to Date Across Seed and Series A FinancingsSOUTH SAN ...

Brisbane, Australia - Newsfile Corp. - December 15, 2025 - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ( ...

Kyverna Therapeutics stock upgraded to Strong Buy after positive phase 2 results for miv-cel in SPS and MG. Read the latest ...

The cell therapy manufacturing sector reached a pivotal inflection point in late 2025, with contract development and ...

QS stock's 2025 rally is backed by Cobra manufacturing gains, Volkswagen funding, first customer billings, B1 samples and pilot-line progress.